[The potentials of combined anti-arrhythmia therapy with the use of neuroactive amino acids in patients with ischemic heart disease].
D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy / Q000503:physiopathology; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy; D005117:Cardiac Complexes, Premature / Q000188:drug therapy / Q000503:physiopathology; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005971:Glutamates / Q000627:therapeutic use*; D018698:Glutamic Acid; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000503:physiopathology; D010640:Phenothiazines / Q000627:therapeutic use; D005082:Physical Exertion; D011802:Quinidine / Q000627:therapeutic use; D013386:Succinates / Q000627:therapeutic use*; D019802:Succinic Acid
D000889:Anti-Arrhythmia Agents; D005971:Glutamates; D010640:Phenothiazines; D013386:Succinates; D018698:Glutamic Acid; C009764:quinidine bisulfate; D019802:Succinic Acid; C046818:ethacizine; D011802:Quinidine
Vozmozhnosti kombinirovannoĭ antiaritmicheskoĭ terapii s ispol'zovaniem neĭroaktivnykh aminokislot u bol'nykh ishemicheskoĭ bolezn'iu serdtsa.